Pathogenesis of Liver Fibrosis
The DOI matches its Crossref record; 220 of the 222 references it cites were found in a registry or an index, and 2 are not checked yet.
Abstract
Liver fibrosis is a major cause of morbidity and mortality worldwide due to chronic viral hepatitis and, more recently, from fatty liver disease associated with obesity. Hepatic stellate cell activation represents a critical event in fibrosis because these cells become the primary source of extracellular matrix in liver upon injury. Use of cell-culture and animal models has expanded our understanding of the mechanisms underlying stellate cell activation and has shed new light on genetic regulation, the contribution of immune signaling, and the potential reversibility of the disease. As pathways of fibrogenesis are increasingly clarified, the key challenge will be translating new advances into the development of antifibrotic therapies for patients with chronic liver disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“STAT3, a member of the STATs family, is a key transcriptional mediator of cellular processes [43, 44].”
From Saikosaponin b1 Attenuates Liver Fibrosis by Blocking STAT3/Gli1 Interaction and Inducing Gli1 Degradation (2025) · cites this paper as [43]
In the citing paper
“they may also derive from portal fibroblasts, bone marrow-derived cells, circulating fibrocytes, [7] and by the controversially discussed epithelial-tomesenchymal (EMT) [8,9] or endothelial-to-mesenchymal (EndoTM) transition.[10,11]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [7]
Citations
Cites
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415
Origins and Mechanisms of miRNAs and siRNAs
Carthew, R. W., & Sontheimer, E. J. (2009) · Cell · doi:10.1016/j.cell.2009.01.035 · Cited by 5,018
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
Self-citationMany roads to maturity: microRNA biogenesis pathways and their regulation
Winter, J., Jung, S., Keller, S., Gregory, R. I., & Diederichs, S. (2009) · Nature Cell Biology · doi:10.1038/ncb0309-228 · Cited by 2,656
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320530 · Cited by 2,649
Mechanisms of Hepatic Fibrogenesis
Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,634
Self-citationEndothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,222
Bendelac, A., Savage, P. B., & Teyton, L. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141711 · Cited by 2,155
Research works printed but not linked: 15
- 10.1172/jci200112373 · DOI · Paper page
- 10.1055/s-2001-17556 · DOI · Paper page
- Stupack DG., 2007, Oncology, 21, 6
- Hehlgans S, 2007, Biochim. Biophys. Acta, 1775, 163
- Omenetti A, 2008, J. Clin. Investig., 118, 3331
- Pinzani M, 1996, Am. J. Pathol., 148, 785
- Sims DE., 1991, Can. J. Cardiol., 7, 431
- Thimgan MS, 1999, Am. J. Physiol., 277, G137
- 10.1136/gut.2005.088690 · DOI · Paper page
- Gao B., 2005, Cell Mol. Immunol., 2, 92
- Anania FA, 1995, Hepatology, 21, 1640
- Connolly MK, 2009, J. Clin. Investig., 119, 3213
- Seki E, 2009, J. Clin. Investig., 119, 1858
- McCrudden R, 2000, Histol. Histopathol., 15, 1159
- 10.1002/hep.23046 · DOI · Paper page
Cited by
Items 401–500 of 1,007
Contribution of Myofibroblasts of Different Origins to Liver Fibrosis
Fausther, M., Lavoie, É. G., & Dranoff, J. A. (2013) · Current Pathobiology Reports · doi:10.1007/s40139-013-0020-0 · Cited by 52
Phenylbutyric acid protects against carbon tetrachloride-induced hepatic fibrogenesis in mice
Wang, J., Chen, X., Zhang, C., Li, T., Zhang, Z., Liu, X., Xu, Y.-B., Wang, H., Li, J., & Xu, D. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.11.007 · Cited by 52
Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation
Liu, Y.-W., Chiu, Y., Fu, S., & Huang, Y. (2015) · Journal of Biomedical Science · doi:10.1186/s12929-015-0168-5 · Cited by 52
Sircana, A., Paschetta, E., Saba, F., Molinaro, F., & Musso, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071745 · Cited by 48
“Integrins modulate proliferation, differentiation and survival through the activation of Hedgehog signaling [30] and other intracellular specifics pathways, including protein kinase C, phosphatidylinositol 3-kinase (PI3K) and mitogen-activated protein kinases (MAPK) [31].”
BackgroundMa, X., Zhou, Y., Qiao, B., Jiang, S., Shen, Q., Han, Y., Liu, A., Chen, X., Wei, L., Zhou, L., et al. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00427.2019 · Cited by 52
Directed differentiation of human induced pluripotent stem cells to hepatic stellate cells
Vallverdú, J., de la Torre, R. A. M. G., Mannaerts, I., Verhulst, S., Smout, A., Coll, M., Ariño, S., Rubio‐Tomás, T., Aguilar‐Bravo, B., Martínez–Sánchez, C., et al. (2021) · Nature Protocols · doi:10.1038/s41596-021-00509-1 · Cited by 52
Retinyl esters form lipid droplets independently of triacylglycerol and seipin
Molenaar, M. R., Yadav, K. K., Toulmay, A., Wassenaar, T. A., Mari, M. C., Caillon, L., Chorlay, A., Lukmantara, I., Haaker, M. W., Wubbolts, R., et al. (2021) · The Journal of Cell Biology · doi:10.1083/jcb.202011071 · Cited by 52
Challa, A. A., Vukmirovic, M., Blackmon, J., & Stefanovic, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042989 · Cited by 52
TRPV4 Channel Inhibits TGF-β1-Induced Proliferation of Hepatic Stellate Cells
Song, Y., Zhan, L., Yu, M., Huang, C., Meng, X., Ma, T., Zhang, L., & Li, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101179 · Cited by 51
Lipid nanoparticles as the drug carrier for targeted therapy of hepatic disorders
Chu, R., Wang, Y., Kong, J., Pan, T. S., Yang, Y., & He, J. F. (2024) · Journal of Materials Chemistry B · doi:10.1039/d3tb02766j · Cited by 51
Resveratrol attenuates the progress of liver fibrosis via the Akt/nuclear factor-κB pathways
Zhang, H., Sun, Q., XU, T., Liang, H., Fu, R., Wu, J., & Ding, J. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4497 · Cited by 51
Yoshida, K., Murata, M., Yamaguchi, T., Matsuzaki, K., & Okazaki, K. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5010007 · Cited by 51
Comparison of diagnostic accuracies of two‐ and three‐dimensional MR elastography of the liver
Morisaka, H., Motosugi, U., Glaser, K. J., Ichikawa, S., Ehman, R. L., Sano, K., Ichikawa, T., & Onishi, H. (2016) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25425 · Cited by 51
Li, Y., Wang, J., Song, K., Liu, S., Zhang, H., Wang, F., Chen, N., Zhai, W., Liang, J., Qin, Z., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1725355 · Cited by 52
Regression of liver fibrosis: evidence and challenges
Sun, Y., Chen, S., & You, H. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000835 · Cited by 51
“Liver fibrosis is the chronic wound-healing process between fibrogenesis and fibrolysis.([1]) Fibrosis, and compensated and decompensated cirrhosis were considered as a sequential process, which was previously thought to be irreversible.”
BackgroundZhou, M., Cheng, M., Huang, T., Hu, R.-H., Zou, G.-L., Li, H., Zhang, B., Zhu, J., Liu, Y., Liu, Y., et al. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i40.6908 · Cited by 51
Kinase Inhibition as Treatment for Acute and Chronic Graft-Versus-Host Disease
Braun, L. M., & Zeiser, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.760199 · Cited by 51
Bian, F., Jiang, H., Man, M., Mai, K., Zhou, H., Xu, W., & He, G. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00285.2016 · Cited by 51
Role of activated hepatic stellate cells in proliferation and metastasis of hepatocellular carcinoma
Lin, N., Chen, Z., Lu, Y., Li, Y., Hu, K., & Xu, R. (2015) · Hepatology Research · doi:10.1111/hepr.12356 · Cited by 47
Wang, L., Yue, Z. D., Guo, M., Fang, L., Bai, L., Li, X., Tao, Y., Wang, S., Liu, Q., Zhi, D., et al. (2016) · BioMed Research International · doi:10.1155/2016/1068528 · Cited by 50
Kuehl, T., & Lagares, D. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.01.020 · Cited by 50
“Tissue fibrosis, characterized by excessive deposition and crosslinking of extracellular matrix (ECM) components, leads to loss of organ architecture, end-stage organ failure and ultimately death [3-7].”
BackgroundSinkus, R., Lambert, S. A., Abd‐Elmoniem, K. Z., Morse, C. G., Heller, T., Guenthner, C., Ghanem, A., Holm, S., & Gharib, A. M. (2018) · NMR in Biomedicine · doi:10.1002/nbm.3956 · Cited by 50
“Additionally, there is an increased presence of fibrogenic and contractile myofibroblasts in the ECM.(1) Collectively these behave as struts within the hepatic tissue, thereby contributing to tissue rigidity.”
BackgroundInfluentialNatural compounds in the chemoprevention of alcoholic liver disease
Tu, Y., Zhu, S., Wang, J., Burstein, E., & Jia, D. (2019) · Phytotherapy Research · doi:10.1002/ptr.6410 · Cited by 50
He, H., Peng, S., Song, X., Jia, R., Zou, Y., Li, L., & Yin, Z. (2021) · Food Science & Nutrition · doi:10.1002/fsn3.2668 · Cited by 50
Zhang, F., Zhang, Z., Kong, D., Zhang, X., Chen, L., Zhu, X., Lu, Y., & Zheng, S. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.09.020 · Cited by 50
Aging enhances liver fibrotic response in mice through hampering extracellular matrix remodeling.
Delire, B., Lebrun, V., Selvais, C., Henriet, P., Bertrand, A., Horsmans, Y., & Leclercq, I. A. (2016) · Aging · doi:10.18632/aging.101124 · Cited by 49
Gu, Y., Wang, R., Chen, P., Li, S., Chai, X., Chen, C., Liu, Y., Cao, Y. W., Lv, D., Hong, Z., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.04.010 · Cited by 49
Yang, J., Kong, W. H., Sung, D. K., Kim, H., Kim, T. H., Lee, K. C., & Hahn, S. K. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2014.10.002 · Cited by 49
Inhalation of vanadium pentoxide and its toxic effects in a mouse model
van der Goes, T. I. F., Rodríguez-Lara, V., González-Villalva, A. E., Lemus, M. R., Cano-Gutiérrez, G., Ustarroz-Cano, M., Colín-Barenque, L., Bizarro‐Nevares, P., García‐Peláez, I., Montaño, L. F., et al. (2014) · Inorganica Chimica Acta · doi:10.1016/j.ica.2014.03.027 · Cited by 49
Protective effects of curcumin against liver fibrosis through modulating DNA methylation
Wu, P., Huang, R., Xiong, Y., & Wu, C. (2016) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(16)30025-5 · Cited by 49
Activation of hepatic stellate cell in Pten null liver injury model
He, L., Gubbins, J., Peng, Z., Medina, V., Fei, F., Asahina, K., Wang, J., Kahn, M., Rountree, C. B., & Stiles, B. L. (2016) · Fibrogenesis & Tissue Repair · doi:10.1186/s13069-016-0045-1 · Cited by 49
Wang, Y., Yang, F., Xue, J., Zhou, X., Luo, L., Ma, Q., Chen, Y.-F., Zhang, J., Zhang, S., & Zhao, L. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01347-16 · Cited by 49
Wu, Y., Bu, F., Yu, H., Li, W., Huang, C., Meng, X., Zhang, L., Ma, T., & Li, J. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.12.002 · Cited by 49
Notch3 regulates the activation of hepatic stellate cells
Chen, Y.-X., Weng, Z.-H., & Zhang, S.-L. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i12.1397 · Cited by 49
PDGFRα in Liver Pathophysiology: Emerging Roles in Development, Regeneration, Fibrosis, and Cancer
Kikuchi, A., & Monga, S. P. (2015) · Gene Expression · doi:10.3727/105221615x14181438356210 · Cited by 40
Rombouts, K., Carloni, V., Mello, T., Omenetti, S., Galastri, S., Madiai, S., Galli, A., & Pinzani, M. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.040 · Cited by 49
Wilmore, J. H. (1991) · Clinics in Sports Medicine · doi:10.1016/s0278-5919(20)30629-3 · Cited by 49
Guo, M., Wang, Z., Dai, J., Fan, H., Yuan, N., Gao, L., Peng, H., & Cheng, X. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154587 · Cited by 51
Liu, Y., Yang, X. F., Jing, Y., Zhang, S., Zong, C., Jiang, J., Sun, K., Li, R., Gao, L., Zhao, X., et al. (2015) · Scientific Reports · doi:10.1038/srep17762 · Cited by 48
Yang, Y. J., Bae, M., Park, Y., Lee, Y., Pham, T. X., Rudraiah, S., Manautou, J. E., Koo, S. I., & Lee, J. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.11.003 · Cited by 48
Wei, X., Chen, Y., & Huang, W. (2018) · BioFactors · doi:10.1002/biof.1432 · Cited by 48
Fibrogenic Activity of MECP2 Is Regulated by Phosphorylation in Hepatic Stellate Cells
Morán‐Salvador, E., Macia, M. G., Sivaharan, A., Sabater, L., Zaki, M. Y. W., Oakley, F., Knox, A., Page, A., Luli, S., Mann, J., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.07.029 · Cited by 48
Yang, Y., Wang, H., Lv, X., Wang, Q., Zhao, H., Yang, F., Yang, Y., & Li, J. (2015) · Biochimie · doi:10.1016/j.biochi.2015.04.019 · Cited by 48
Cirrhosis and chronic liver failure
Hsu, E. K., & Murray, K. F. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139012102.006 · Cited by 48
Hyperoside as a Potential Natural Product Targeting Oxidative Stress in Liver Diseases
Jang, E. (2022) · Antioxidants · doi:10.3390/antiox11081437 · Cited by 47
Jia, B., Guo, M., Li, G., Yu, D., Zhang, X., Lan, K., & Deng, Q. (2014) · Journal of Virology · doi:10.1128/jvi.03106-14 · Cited by 47
Yang, D., Gao, Y.-H., Tan, K.-B., Zuo, Z.-X., Yang, W.-X., Hua, X., Li, P.-J., Zhang, Y., & Wang, G. (2013) · Gene Therapy · doi:10.1038/gt.2013.41 · Cited by 47
Zhou, Q., Guan, W., Qiao, H., Cheng, Y., Li, Z., Zhai, X., & Zhou, Y. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.10.001 · Cited by 47
Zhang, X., Feng, M., Liu, X., Bai, L., Kong, M., Chen, Y., Zheng, S., Liu, S., Wan, Y. Y., Duan, Z., et al. (2015) · Translational research · doi:10.1016/j.trsl.2015.10.008 · Cited by 48
“However, a previous study demonstrated that the anti-CD25 mAb selectively depletes cells with the highest levels of CD25 expression, and the altered intensity of the immune response was more consistent with the depletion of Tregs than that of effector T cells.(28) A study successfully examined the role of Tregs in lun…”
MethodIdentification of novel targets for the diagnosis and treatment of liver fibrosis
Fagone, P., Mangano, K., Mammana, S., Pesce, A., PESCE, A., Caltabiano, R., Giorlandino, A., Portale, T. R., Cavalli, E., Lombardo, G. A. G., et al. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2264 · Cited by 47
Kang, N., Shah, V. H., & Urrutia, R. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0542 · Cited by 46
Hydrogen donors and acceptors and basic amino acids jointly contribute to carcinogenesis
Tang, M., Zhou, Y., Li, Y., Zou, J., Yang, B.-C., Cai, L., Zhang, X., & Liu, Q. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2016.11.014 · Cited by 47
Cao, H., Li, S., Xie, R., Xu, N., Qian, Y., Chen, H., Hu, Q.-Y., Quan, Y., Yu, Z., Liu, J., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00187 · Cited by 47
Gasotransmitters: Potential Therapeutic Molecules of Fibrotic Diseases
Chen, Y., Yuan, S., Cao, Y., Kong, G., Jiang, F., Li, Y., Wang, Q., Tang, M., Zhang, Q., Wang, Q., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/3206982 · Cited by 47
“It plays a critical role in promoting fibrotic cell proliferation, collagen secretion, protease inhibitor production, and extracellular matrix (ECM) deposition in tissues [13].”
BackgroundInfluentialUpdate on implications and mechanisms of angiogenesis in liver fibrosis
Zhang, Z., Zhang, F., Lu, Y., & Zheng, S. (2014) · Hepatology Research · doi:10.1111/hepr.12415 · Cited by 47
Kassel, K. M., Sullivan, B. P., Cui, W., Copple, B. L., & Luyendyk, J. P. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.06.011 · Cited by 47
Liu, C., Wang, G., Chen, G., Mu, Y., Zhang, L., Hu, X., Sun, M., Liu, C., & Liu, P. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-51 · Cited by 47
Wu, K., Ye, C., Lin, L., Chu, Y., Ji, M., Dai, W., Zeng, X. Y., & Lin, Y. (2016) · Clinical Science · doi:10.1042/cs20160334 · Cited by 47
Zou, Y., Li, S., Li, Z., Song, D., Zhang, S., & Yao, Q. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.01.012 · Cited by 46
The liver as an immunological barrier redefined by single‐cell analysis
Stamataki, Z., & Swadling, L. (2020) · Immunology · doi:10.1111/imm.13193 · Cited by 46
Association of serum vitamin C with liver fibrosis in adults with nonalcoholic fatty liver disease
Zhao, Y., & Li, H. (2022) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2022.2041085 · Cited by 46
“Hepatic fibrosis is a protective response to chronic liver injury caused by multiple etiologies, including NAFLD [2,3].”
BackgroundTrust Your Gut: The Association of Gut Microbiota and Liver Disease
Manzoor, R., Ahmed, W., Afify, N., Memon, M., Yasin, M., Memon, H., Rustom, M., Akeel, M. A., & Alhajri, N. (2022) · Microorganisms · doi:10.3390/microorganisms10051045 · Cited by 47
“This results in thickened hepatic septae and collagen cross-linking [52].”
BackgroundAbdelnabi, M. N., Hassan, G. S., & Shoukry, N. H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1437046 · Cited by 46
3,3′‐Diindolylmethane ameliorates experimental hepatic fibrosis via inhibiting miR ‐21 expression
Zhang, Z., Gao, Z., Hu, W., Yin, S., Wang, C., Zang, Y., Chen, J., Zhang, J., & Dong, L. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12323 · Cited by 46
Gadd, V. L., Melino, M., Roy, S., Horsfall, L. U., O'Rourke, P. K., Williams, M. R., Irvine, K. M., Sweet, M. J., Jonsson, J. R., Clouston, A. D., et al. (2012) · Liver International · doi:10.1111/liv.12050 · Cited by 46
Karsdal, M. A., Detlefsen, S., Daniels, S. J., Nielsen, M. J., Krag, A. A., & Schuppan, D. (2019) · Hepatology · doi:10.1002/hep.30969 · Cited by 46
“Inspired by a previous work.(40) KC, Kupffer cell.”
MethodSuflețel, R. T., Melincovici, C. S., Gheban, B., Zaharie, T., & Mihu, C. M. (2021) · Romanian Journal of Morphology and Embryology · doi:10.47162/rjme.61.3.01 · Cited by 46
Tissue mechanics coevolves with fibrillar matrisomes in healthy and fibrotic tissues
Dooling, L. J., Saini, K., Anlaş, A. A., & Discher, D. E. (2022) · Matrix Biology · doi:10.1016/j.matbio.2022.06.006 · Cited by 46
Salloum, S., Holmes, J. A., Jindal, R., Bale, S. S., Brisac, C., Alatrakchi, N., Lidofsky, A., Kruger, A. J., Fusco, D. N., Luther, J., et al. (2016) · Hepatology · doi:10.1002/hep.28766 · Cited by 46
Nuclear receptors in liver fibrosis
Königshofer, P., Brusilovskaya, K., Petrenko, O., Hofer, B. S., Schwabl, P., Trauner, M., & Reiberger, T. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166235 · Cited by 45
A FAPα-activated MRI nanoprobe for precise grading diagnosis of clinical liver fibrosis
Gao, J., Wang, Y., Meng, X., Wang, X., Han, F., Xing, H., Lv, G., Zhang, L., Wu, S., Jiang, X., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52308-3 · Cited by 45
Shaaban, A. A., Shaker, M. E., Zalata, K. R., El‐Kashef, H. A., & Ibrahim, T. M. (2013) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2013.10.008 · Cited by 45
Diamond, D. L., Krasnoselsky, A. L., Burnum-Johnson, K., Monroe, M. E., Webb‐Robertson, B., McDermott, J., Yeh, M. M., Dzib, J. F. G., Susnow, N. J., Strom, S., et al. (2012) · Hepatology · doi:10.1002/hep.25649 · Cited by 45
Role of histone deacetylases(HDACs) in progression and reversal of liver fibrosis
Li, X., Wu, X., Xu, T., Li, X., Yang, Y., Li, W., Huang, C., Meng, X., & Li, J. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.07.003 · Cited by 45
Preclinical detection of liver fibrosis using dual-modality photoacoustic/ultrasound system
van den Berg, P. J., Bansal, R., Daoudi, K., Steenbergen, W., & Prakash, J. (2016) · Biomedical Optics Express · doi:10.1364/boe.7.005081 · Cited by 45
p300/CBP as a Key Nutritional Sensor for Hepatic Energy Homeostasis and Liver Fibrosis
Yao, W., Wang, T., & Huang, F. (2018) · BioMed Research International · doi:10.1155/2018/8168791 · Cited by 45
Damba, T., Zhang, M., Buist‐Homan, M., van Goor, H., Faber, K. N., & Moshage, H. J. (2019) · Nitric Oxide · doi:10.1016/j.niox.2019.08.004 · Cited by 45
“Therefore, it is important to understand the mechanisms that lead to hepatic stellate cell activation and hepatic fibrosis [3,4].”
BackgroundChen, X., Li, X., Chen, Y., Zhu, S., Li, H.-D., Chen, S., Wang, J., Pan, X., Bu, F., Huang, C., et al. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.105838 · Cited by 45
Lin, X., Liu, H., Hsu, S.-J., Zhang, R., Chen, J., Chen, J., Gao, D., Cui, J., Ren, Z., & Chen, R. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01568-0 · Cited by 45
Yuan, Q., Zhang, J., Liu, Y., Chen, H., Liu, H., Wang, J., Niu, M., Hou, L., Wu, Z., Chen, Z., et al. (2022) · The Journal of Pathology · doi:10.1002/path.5856 · Cited by 46
Zhou, F., Wang, A., Li, D., Wang, Y., & Lin, L. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.01.009 · Cited by 45
“Liver fibrosis is a wound-healing response characterized by the accumulation of extracellular matrix (ECM) following either acute or chronic liver injury (Hernandez-Gea and Friedman, 2011).”
BackgroundInfluentialZhang, H., Chen, Q., Dahan, A., Xue, J., Wei, L., Tan, W., & Zhang, G. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.05.041 · Cited by 44
Circadian Rhythms in Liver Physiology and Liver Diseases
Tong, X., & Yin, L. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c120017 · Cited by 44
The role of p53 in liver fibrosis
Yu, S., Ji, G., & Zhang, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1057829 · Cited by 44
“Once the primary disease is controlled or tissue damage is reduced, the activated HSCs can return to a quiescent state (Hernandez-Gea and Friedman, 2011; Seki and Brenner, 2015).”
BackgroundRecent advances in liver‐on‐chips: Design, fabrication, and applications
Qiu, L., Kong, B., Kong, T., & Wang, H. (2023) · Smart Medicine · doi:10.1002/smmd.20220010 · Cited by 44
Zhan, L., Yang, Y., Ma, T., Huang, C., Meng, X., Zhang, L., & Li, J. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2298-6 · Cited by 45
Hepatic Stellate Cells in Liver Fibrosis and siRNA-Based Therapy
Omar, R., Yang, J., Liu, H., Davies, N. M., & Gong, Y. (2016) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2016_6 · Cited by 44
Origin and role of hepatic myofibroblasts in hepatocellular carcinoma
Yavuz, B. G., Pestana, R. C., Abugabal, Y. I., Krishnan, S., Chen, J., Hassan, M. M., Wolff, R. A., Rashid, A., Amin, H. M., & Kaseb, A. O. (2020) · Oncotarget · doi:10.18632/oncotarget.27532 · Cited by 45
He, C., Yang, Y., Zheng, K., Chen, Y., Liu, S., Li, Y., Han, Q., Zhao, R. C., Wang, L., & Zhang, F. (2021) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622321993442 · Cited by 45
Kong, D., Zhang, F., Donghua, W., Zhu, X., Zhang, X., Chen, L., Lu, Y., & Zheng, S. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12147 · Cited by 44
Pérez-Vargas, J. E., Zarco, N., Shibayama, M., Segovia, J., Tsutsumi, V., & Muriel, P. (2014) · Pharmacology · doi:10.1159/000366206 · Cited by 44
Toxicity Assessment of Cadinene Sesquiterpenes from Eupatorium adenophorum in Mice
Ouyang, C., Liu, X., Liu, Q., Bai, J., Li, H.-Y., Li, Y., Wang, Q., Yan, D., Mao, L., Cao, A., et al. (2014) · Natural Products and Bioprospecting · doi:10.1007/s13659-014-0050-2 · Cited by 44
Manchanda, M., Das, P., Gahlot, G. P. S., Singh, R., Roeb, E., Roderfeld, M., Gupta, S. D., Saraya, A., Pandey, R. M., & Chauhan, S. S. (2017) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2017.25 · Cited by 44
Farnesoid X receptor: From Structure to Function and Its Pharmacology in Liver Fibrosis
Ding, C., Wang, Z., Dou, X., Yang, Q., Ning, Y., Kao, S., Sang, X., Hao, M., Wang, K., Peng, M., et al. (2023) · Aging and Disease · doi:10.14336/ad.2023.0830 · Cited by 44
“Numerous factors associated with prolonged chronic stimulation can trigger inflammation and necrosis of hepatocytes, thereby promoting the activation of hepatic stellate cells (HSCs) and resulting in hepatic fibrosis [16, 17].”
BackgroundCobbold, J., Patel, D., & Taylor-Robinson, S. D. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07127.x · Cited by 43
Yu, X., Guo, R., Ming, D., Su, M., Lin, C., Deng, Y., Lin, Z., & Su, Z. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12459 · Cited by 43
Pan, T., Wang, P., Huang, C., Leu, Y., Wu, T.-H., Wu, Y.-R., & You, J. (2015) · Scientific Reports · doi:10.1038/srep11734 · Cited by 43
The roles of Tenascin C and Fibronectin 1 in adhesive capsulitis: a pilot gene expression study
Cohen, C., Leal, M. F., Belangero, P. S., de Figueiredo, E. A., Smith, M. D. A. C., Andreoli, C. V., Pochini, A. D. C., Cohen, M., Ejnisman, B., & Faloppa, F. (2016) · Clinics · doi:10.6061/clinics/2016(06)07 · Cited by 43
Zhang, S., Wang, Z., Zhu, J., Xu, T., Zhao, Y., Zhao, H., Tang, F., Li, Z., Zhou, J., Gao, D., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00976 · Cited by 43
Kindlin-2 regulates hepatic stellate cells activation and liver fibrogenesis
Yu, J., Hu, Y., Gao, Y., Li, Q., Zeng, Z., Li, Y., & Chen, H. (2018) · Cell Death Discovery · doi:10.1038/s41420-018-0095-9 · Cited by 35
Metadata
- Authors
- Hernandez-Gea, V., & Friedman, S. L.
- Affiliations
- Division of Liver Diseases, Mount Sinai School of Medicine, New York, New York 10029;
- Icahn School of Medicine at Mount Sinai (US)
- ORCID
- Friedman, Scott L.
- Venue
- Annual Review of Pathology: Mechanisms of Disease
- Publisher
- Annual Reviews
- Published
- 2011-02-28
- Volume
- 6
- Issue
- 1
- Pages
- 425-456
- ISSN
- 1553-4006 (ISSN-L)
- 1553-4014
- OpenAlex
- W2142988890
- Cited by
- 1,809
- References
- 220
- Citations by year
- 2026: 81 · 2025: 123 · 2024: 121 · 2023: 112 · 2022: 148 · 2021: 174 · 2020: 145 · 2019: 119 · 2018: 117 · 2017: 131 · 2016: 136 · 2015: 124 · 2014: 97 · 2013: 76 · 2012: 67
- FWCI
- 10.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Pathology Mechanisms of Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- liver fibrosis, hepatic stellate cell activation, extracellular matrix, chronic viral hepatitis, hepatic steatosis, obesity, immune signaling, genetic control, fibrosis reversibility, antifibrotic therapy, chronic liver disease
- MeSH terms
- Humans, Liver, Liver Cirrhosis, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.